INO-4700

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy VolunteersNCT04588428Inovio PharmaceuticalsPhase 2Completed2023-01-19Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.